176 related articles for article (PubMed ID: 12889216)
1. Assessment of gastrointestinal involvement.
Clements PJ; Becvar R; Drosos AA; Ghattas L; Gabrielli A
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S15-8. PubMed ID: 12889216
[TBL] [Abstract][Full Text] [Related]
2. Assessment of vascular involvement.
Kahaleh B; Meyer O; Scorza R
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S9-14. PubMed ID: 12889215
[TBL] [Abstract][Full Text] [Related]
3. Assessment of disease activity.
Valentini G; Silman AJ; Veale D
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S39-41. PubMed ID: 12889221
[TBL] [Abstract][Full Text] [Related]
4. Assessment of kidney involvement.
Steen VD; Mayes MD; Merkel PA
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S29-31. PubMed ID: 12889219
[TBL] [Abstract][Full Text] [Related]
5. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.
Kaniecki T; Abdi T; McMahan ZH
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101666. PubMed ID: 33676855
[TBL] [Abstract][Full Text] [Related]
6. Assessment of lung involvement.
Matucci-Cerinic M; D'Angelo S; Denton CP; Vlachoyiannopoulos P; Silver R
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S19-23. PubMed ID: 12889217
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal manifestations in Hungarian scleroderma patients.
Szamosi S; Szekanecz Z; Szucs G
Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis and the gut.
Butt S; Emmanuel A
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
[TBL] [Abstract][Full Text] [Related]
9. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc.
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S49-56. PubMed ID: 12889224
[No Abstract] [Full Text] [Related]
10. Conclusion and identification of the core set of variables to be used in clinical investigations.
Valentini G; Medsger TA; Silman AJ; Bombardieri S
Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S47-8. PubMed ID: 12889223
[No Abstract] [Full Text] [Related]
11. Gastrointestinal involvement in systemic sclerosis: an update.
McMahan ZH
Curr Opin Rheumatol; 2019 Nov; 31(6):561-568. PubMed ID: 31389815
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the gastrointestinal tract by progressive systemic sclerosis.
Cassada WA; Armstrong RH; Neal MP
South Med J; 1968 May; 61(5):475-81. PubMed ID: 5648693
[No Abstract] [Full Text] [Related]
13. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis.
Bae S; Allanore Y; Furst DE; Bodukam V; Coustet B; Morgaceva O; Maranian P; Khanna D
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):57-63. PubMed ID: 23910611
[TBL] [Abstract][Full Text] [Related]
14. Systemic scleroderma involving the GI tract.
Baekelandt M; Ponette E
J Belge Radiol; 1989 Dec; 72(6):502-3. PubMed ID: 2621202
[No Abstract] [Full Text] [Related]
15. Gastrointestinal manifestations of scleroderma.
Young MA; Rose S; Reynolds JC
Rheum Dis Clin North Am; 1996 Nov; 22(4):797-823. PubMed ID: 8923597
[TBL] [Abstract][Full Text] [Related]
16. A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Gorga M; Mihai C; Soare AM; Dobrotă R; Gherghe AM; Stoica V
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S61-7. PubMed ID: 26316302
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.
Volkmann ER; McMahan Z
Curr Opin Rheumatol; 2022 Nov; 34(6):328-336. PubMed ID: 35993874
[TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis.
Gualtierotti R; Ingegnoli F; Two R; Meroni PL; Khanna D; Adorni G; Becciolini A; Ciavarella T; Marfia G; Murgo A; Scalone L; Ughi N; Zeni S;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S55-60. PubMed ID: 26339890
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and management of gastrointestinal manifestations in scleroderma.
Kirby DF; Chatterjee S
Curr Opin Rheumatol; 2014 Nov; 26(6):621-9. PubMed ID: 25207461
[TBL] [Abstract][Full Text] [Related]
20. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
